checkAd
    Startseite > Aktien > SciSparc > Nachrichten
    SciSparc
    Aktie
    ISIN: IL0010951403 WKN: A1CY7H SYM: SPRC Land Israel
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    0,8933
     
    USD
    +2,68 %
    +0,0233 USD
    Letzter Kurs 02:00:00 NYSE
    Geldkurs
    20.06.24
    0,8800
     
    USD
    100 STK
    Briefkurs
    20.06.24
    0,9400
     
    USD
    600 STK

    SciSparc Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    SciSparc Secures Strategic Advantage with Grant of European Patent
    31.05.24 · globenewswire · SciSparc
    SciSparc to Acquire AutoMax
    11.04.24 · globenewswire · SciSparc
    SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
    27.03.24 · globenewswire · SciSparc
    SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
    21.03.24 · globenewswire · SciSparc
    SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
    18.03.24 · globenewswire · SciSparc
    SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
    14.03.24 · globenewswire · SciSparc
    SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
    12.03.24 · globenewswire · SciSparc
    SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder
    08.03.24 · globenewswire · SciSparc
    SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe
    07.03.24 · globenewswire · SciSparc
    SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
    06.03.24 · globenewswire · SciSparc
    SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
    29.02.24 · globenewswire · SciSparc
    SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
    27.02.24 · globenewswire · SciSparc